Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
646 |
|
| Actual shortage: | 67 (10%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 16 (2%) | |
| Resolved: | 562 (87%) | |
Discontinuation Reports |
72 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 54 (75%) | |
| Reversed: | 11 (15%) | |
Late reports |
52 (7%) |
|
Overdue reports |
17 (23%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RIZATRIPTAN | 10MG | TABLET | Resolved | 2024-10-21 | 2024-12-19 | 240737 |
| RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-07-30 | 2019-12-11 | 90221 |
| RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-19 | 2020-08-05 | 109008 |
| RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2020-03-19 | 2020-08-05 | 109013 |
| RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-02-26 | 2024-04-04 | 220668 |
| RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-11-11 | 2025-02-28 | 242422 |
| RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2024-12-23 | 2025-02-28 | 246306 |
| ROPINIROLE | 0.25MG | TABLET | Resolved | 2017-09-27 | 2017-10-16 | 23677 |
| ROPINIROLE | 0.25MG | TABLET | Resolved | 2017-11-21 | 2017-12-16 | 29895 |
| ROPINIROLE | 0.25MG | TABLET | Resolved | 2019-01-15 | 2019-02-28 | 72242 |
| ROPINIROLE | 0.25MG | TABLET | Resolved | 2019-06-19 | 2019-09-07 | 87069 |
| ROPINIROLE | 0.25MG | TABLET | Resolved | 2019-12-11 | 2020-02-04 | 100962 |
| ROPINIROLE | 1MG | TABLET | Resolved | 2020-02-27 | 2020-04-08 | 107312 |
| ROPINIROLE | 0.25MG | TABLET | Resolved | 2021-08-03 | 2021-10-01 | 143442 |
| ROPINIROLE | 1MG | TABLET | Resolved | 2021-08-03 | 2022-04-05 | 143447 |
| ROPINIROLE | 1MG | TABLET | Avoided shortage | 2021-09-24 | 2024-02-15 | 146199 |
| ROPINIROLE | 0.25MG | TABLET | Avoided shortage | 2021-09-30 | 2021-10-08 | 146482 |
| ROPINIROLE | 1MG | TABLET | Resolved | 2021-10-08 | 2022-04-06 | 146927 |
| ROPINIROLE | 0.25MG | TABLET | Resolved | 2021-10-08 | 2024-02-15 | 146947 |
| ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-06-22 | 2023-08-08 | 196099 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| INDAPAMIDE | 1.25MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2453 |
| LORAZEPAM | 0.5MG | TABLET | Reversed | 2017-03-14 | 2017-07-31 | 2430 |
| LORAZEPAM | Discontinued | 2020-02-27 | 2020-02-27 | 107347 | ||
| LORAZEPAM | 1.0MG | TABLET | Discontinued | 2021-05-17 | 2021-11-16 | 139511 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-08-12 | 2022-02-06 | 144029 |
| LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-12-16 | 2021-12-17 | 151293 |
| MINOCYCLINE | Discontinued | 2019-01-22 | 2019-01-22 | 73236 | ||
| MINOCYCLINE | Discontinued | 2019-01-22 | 2019-01-22 | 73239 | ||
| MORPHINE SR | 15MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-04-08 | 2020-06-13 | 111515 |
| MORPHINE SR | 30MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-04-08 | 111518 |
| MORPHINE SR | 60MG | TABLET (EXTENDED-RELEASE) | To be discontinued | 2020-04-08 | 2020-06-03 | 111521 |
| OXYBUTYNIN | 5MG | TABLET | Discontinued | 2025-08-11 | 2025-10-12 | 264958 |
| OXYBUTYNIN | 5MG | TABLET | Discontinued | 2025-08-11 | 2025-08-12 | 264961 |
| OXYCODONE/ACET | 5MG 325MG | TABLET | Discontinued | 2020-04-08 | 2020-06-09 | 111527 |
| OXYCODONE/ACET | 5MG 325MG | TABLET | Discontinued | 2020-04-08 | 2020-06-09 | 111531 |
| PANTOPRAZOLE T | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2025-10-27 | 2025-10-28 | 270365 |
| PRAMIPEXOLE | 0.25MG | TABLET | Discontinued | 2019-03-26 | 2019-03-27 | 79465 |
| PRAMIPEXOLE | 0.5MG | TABLET | Discontinued | 2019-03-26 | 2019-03-27 | 79468 |
| PRAMIPEXOLE | 1MG | TABLET | Discontinued | 2019-03-26 | 2019-03-27 | 79471 |
| RAMIPRIL-HCTZ | 12.5MG 10.0MG | TABLET | Discontinued | 2017-03-16 | 2017-03-16 | 3023 |